FDA Investigator John R Carlson
John R Carlson has conducted inspections on 125 sites in 2 countries as of 10 Mar 2020. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
125
Last Inspection Date:
10 Mar 2020
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Italy
FDA Investigators that have inspected at least one site in common with John R Carlson:
Abby E Pelletier,
Aireen V Mendoza,
Aldo J Quintana,
Alice C Silva,
Alysia M Salonia,
Alyssa R Favro,
Amber G Wardwell,
Amy C Jordan,
Andrew J Seaborn,
Andrew M Barlow,
Anne E Carpenter,
Anthony P Costello,
Arie C Menachem,
Atricia L Irons,
Bradford L Swanson,
Brandy L Couillard,
Brandy L Gillilan,
Camerson E Moore,
Carl A Huffman, III,
Carla E Lavallee,
Cassandra L Abellard,
Christine L Williams,
Christopher K Vantwuyver,
Christopher M Elliott,
Christy,
Clinton V Giustra,
Daniel E Needham,
Daniel L Zheng,
Darin S Wiegers,
David P King,
Dean R Rugnetta,
Diantha M Bleau,
Diantha M Turner,
Douglas S Joslin,
Eduardo L Rodriguez,
Elise L Mcdevitt,
Ellen P Madigan,
Emily J Schramm,
Erica B Raphael,
Erich P Garger,
Erin P Conlin,
Gale E Ryan,
Garry H Stewart,
Gerard D Difiore,
Hien Albright,
Intkhab H Wahla,
Isaac N Baah,
Jackson Y See,
Jamie S Mathews,
Jason A Rossi,
Jason D Tenney,
Jeffery A Hangartner,
Jessica I Newman,
John L Zaccone,
John P Mistler,
John P Shelton,
John S Hartford,
Joseph B Cascio,
Joseph Foley,
Joseph T Frost,
Joyce A Kellett,
Juan Rjimenez Garcia,
Kathleen A Sousa,
Kathleen E Mcafoose,
Kathleen M Curry,
Kevin Bernardo,
Kristie Ferreira,
Lauren M Lawrance,
Laurie B Frazier,
Liz M Otero,
Lorayne A Mcguinness,
Lori A Holmquist,
Louis Christy,
Lyndsay M Perryman,
Marcia M Laughrey,
Margaret E Walsh,
Marie Elena C Puleo,
Martin J Guardia,
Maryam Tabatabaie,
Matthew D Silverman,
Megan A Haggerty,
Michael E Antaya,
Michelle M Noe Varga,
Monique C Lo,
Nasser Yazdani, DVM, MPH,
Nichole B Murphy,
Osama A Khatib,
Pamela L Ogonowski,
Paul M Gelfand,
Paul P Geraci,
Paula M Laplant,
Philip H Lafleur,
Philip Kreiter,
Ramcharan S Khalsa,
Ramon E Martinez,
Rebecca A Coleman,
Rebecca B Welch,
Richard B Mcaroy,
Richard F Hapke,
Richard L Licari,
Robert E Teel,
Robert J Martin,
Robert O'brian,
Rosa M Santiago,
Rupa Pradhan,
Sean M Tessicini,
Shawn M Bogdan,
Slater K Bartlett,
Sonia E Ortiz,
Stacey S Degarmo,
Stephen C Smith,
Tania K Mercado,
Teddy Tom,
Thomas Cote,
Thomas Siebertz,
Thomas W Nerney,
Troy R Petrillo,
Victoria Rosales,
Victoria Taylor,
Wendy A Johnecheck,
William K Dagley
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more